Scarica l'app Stockscreener
53.17
3.99%
2.04
Dopo l'orario di chiusura:
53.17
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$51.13
Aprire:
$51.3
Volume 24 ore:
503.66K
Relative Volume:
1.17
Capitalizzazione di mercato:
$1.84B
Reddito:
-
Utile/perdita netta:
$-91.00M
Rapporto P/E:
-14.49
EPS:
-3.67
Flusso di cassa netto:
$-74.38M
1 W Prestazione:
-1.38%
1M Prestazione:
+11.40%
6M Prestazione:
-14.86%
1 anno Prestazione:
+27.75%
Intervallo 1D:
$51.03
$53.66
Intervallo di 1 settimana:
$51.01
$55.52
Portata 52W:
$30.82
$68.73
Disc Medicine Inc Stock (IRON) Company Profile
Nome
Disc Medicine Inc
Settore
Industria
Telefono
(617) 674-9274
Indirizzo
321 ARSENAL STREET, SUITE 101, WATERTOWN
Confronta IRON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
53.17 | 1.84B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-11 | Ripresa | Raymond James | Strong Buy |
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-04-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-05-17 | Iniziato | Raymond James | Outperform |
| 2023-04-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Iniziato | Stifel | Buy |
| 2023-04-20 | Iniziato | Morgan Stanley | Overweight |
| 2023-03-23 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-28 | Iniziato | SVB Securities | Outperform |
Mostra tutto
Disc Medicine Inc Borsa (IRON) Ultime notizie
Insider Sell: Jean Franchi Sells 2,000 Shares of Disc Medicine Inc (IRON) - GuruFocus
Disc Medicine (NASDAQ:IRON) Given Buy Rating at HC Wainwright - Defense World
Analysts Offer Predictions for Disc Medicine Q2 Earnings - Defense World
Raymond James Resumes Coverage on Disc Medicine (IRON) With a Strong Buy Rating - MSN
Disc Medicine stock price target maintained at $118 by H.C. Wainwright - Investing.com
Disc Medicine (IRON) Maintains Buy Rating and Price Target | IRO - GuruFocus
Disc Medicine (IRON) Maintains Buy Rating and Price Target | IRON Stock News - GuruFocus
Disc Medicine’s (IRON) Outperform Rating Reaffirmed at Wedbush - Defense World
First Week of December 19th Options Trading For Disc Medicine (IRON) - Nasdaq
Long Term Trading Analysis for (IRON) - news.stocktradersdaily.com
Disc Medicine shareholders vote on executive pay and board members By Investing.com - Investing.com Canada
Disc Medicine shareholders vote on executive pay and board members - Investing.com Australia
Disc Medicine Holds 2025 Annual Stockholders Meeting - TipRanks
Disc Medicine Presents Positive Clinical Data Updates Across Por - GuruFocus
Disc Medicine (IRON) Highlights Research Advances at EHA 2025 | - GuruFocus
Disc Medicine reports positive data from clinical programs at EHA By Investing.com - Investing.com South Africa
Disc Medicine reports positive data from clinical programs at EHA - Investing.com Australia
Disc Medicine Highlights Positive Clinical Data for Bitopertin, DISC-0974, and DISC-3405 at EHA 2025; Management to Host Corporate Update Call - Nasdaq
Disc Medicine Presents Positive Clinical Data Updates - GlobeNewswire
Disc Medicine Reports Breakthrough Clinical Data Across 3 Blood Disease Programs | IRON Stock News - Stock Titan
Disc Medicine (NASDAQ:IRON) Now Covered by Analysts at Raymond James - Defense World
10 Best Small-Cap Growth Stocks to Buy According to Analysts - Insider Monkey
IRON Stock: Disc Medicine (IRON) Receives Strong Buy Rating from - GuruFocus
California State Teachers Retirement System Sells 1,436 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Cantor Fitzgerald Estimates Disc Medicine FY2026 Earnings - Defense World
Disc Medicine (IRON) Rated Strong Buy by Raymond James | IRON St - GuruFocus
Disc Medicine chief medical officer sells $149,800 in stock By Investing.com - Investing.com India
Insider Sell: William Savage Sells Shares of Disc Medicine Inc (IRON) - GuruFocus
Disc Medicine chief medical officer sells $149,800 in stock - Investing.com
Millennium Management LLC Buys Shares of 7,879 Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Ameriprise Financial Inc. Invests $335,000 in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Bank of America Corp DE Reduces Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of “Buy” from Analysts - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Shares Sold by Nuveen Asset Management LLC - Defense World
Disc Medicine to Participate in Upcoming Investor Conferences - GlobeNewswire
Disc Medicine Sets Double Conference Appearance: Jefferies and Goldman Sachs Healthcare Events - Stock Titan
BNP Paribas Financial Markets Invests $324,000 in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Stock Position Raised by Deutsche Bank AG - Defense World
Medical Marijuana (OTCMKTS:MJNA) Stock Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Disc Medicine Shows Improved Relative Price Performance; Still Shy Of Benchmark - MSN
Disc Medicine’s chief medical officer sells $334,128 in stock By Investing.com - Investing.com Canada
Disc Medicine’s chief medical officer sells $334,128 in stock - Investing.com
Porphyria Pipeline 2025: Groundbreaking Clinical - openPR.com
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Northern Trust Corp - Defense World
Commit To Buy Disc Medicine At $35, Earn 14.1% Annualized Using Options - Nasdaq
Disc Medicine Announces Multiple Presentations Across Portfolio - GuruFocus
Disc Medicine, Inc. to Present Key Data from Hematology Portfolio at EHA 2025 Congress - Nasdaq
Disc Medicine Announces Multiple Presentations Across - GlobeNewswire
Disc Medicine Reveals First Disease-Modifying EPP Treatment Data Among 6 Clinical Updates at EHA 2025 - Stock Titan
Disc Medicine Inc Azioni (IRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Disc Medicine Inc Azioni (IRON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Franchi Jean M. | Chief Financial Officer |
Jun 16 '25 |
Sale |
52.26 |
2,000 |
104,519 |
67,530 |
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):